Argues that novel 5-HT2A agonist compounds can be used in pharmaceutical compositions to treat psychosis, mental illness, and CNS disorders.
Abstract
High Resolution Image Download MS PowerPoint Slide Provided herein are novel serotonergic psychedelic agents as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating psychosis, mental illness and central nervous system (CNS) disorders, and processes for preparing such compounds.